Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI: A Pilot Randomized Trial of Reperfusion Injury Biomarkers and Functional Recovery
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT06850831
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA
- Registry
-
NCT06850831
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Indonesia
- Registry status
- Completed
Technical summary
Registry record NCT06850831. Randomized; double masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2026-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Intracoronary N-Acetylcysteine During Primary PCI in STEMI: A Pilot Randomized Trial of Reperfusion Injury Biomarkers and Functional Recovery
- Condition
- STEMI - ST Elevation Myocardial Infarction (MI)
- Condition
- Primary PCI (percutaneous coronary intervention) - STEMI
- Intervention (Drug)
- Antipac
- Lead sponsor
- dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA
Record details
- Record id
cardio:ct-nct06850831- Content hash
b56857bde8faf619128c9c0e2442b2609b1c4c8c85893549b393f30bcf4c4ff5